Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51.8Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M1.5EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)21.3Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.4PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M900,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XTL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

XTL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

XTL: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about XTL:

    News about XTL:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Thursday links: a tightrope walk May 26 2016
    XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 May 16 2016
    New highs for the market? May 09 2016
    Where to Invest if the Fed Stays Dovish (XLU,XTL) Apr 14 2016
    Triple digit gains in Dow Apr 12 2016
    The U.S. stock market has two surprising new stars Apr 07 2016
    XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of... Mar 21 2016
    Lupus Thought Leader Daphna Paran, MD, Named Medical Director of XTL Biopharmaceuticals Mar 09 2016
    XTL Biopharmaceuticals Expands Global IP Portfolio With Issued Patent in Hungary for Lupus Drug... Mar 02 2016
    XTL Biopharmaceuticals Receives European Medicines Agency's SME Status Feb 22 2016
    XTL Biopharmaceuticals' Lupus Drug hCDR1 Granted Patent for Pharmaceutical Composition &... Feb 10 2016
    XTL Biopharmaceuticals Joins Corporate Advisory Council of the Lupus Foundation of America Jan 27 2016
    XTL Biopharmaceuticals Announces Encouraging Feedback from U.S. FDA on its Upcoming IND Filing for... Jan 25 2016
    What Lies Ahead for Telecom ETFs in 2016? Jan 19 2016
    XTL Biopharmaceuticals Advances Formulation of its hCDR1 Drug for Clinical Trials in the Treatment... Jan 13 2016
    XTL Biopharmaceuticals Submits Protocol to Yeda for Advanced Clinical Trial of hCDR1 in the... Jan 11 2016
    FEZ and EWJ Fall as Crude Oil Prices Plunge Further Dec 14 2015
    DuPont-Dow Megadeal Talk Stirs Materials ETFs Dec 09 2015
    Kite Pharma Leads IBB’s Mid-Caps on Its Zuma-1 Phase 1 Results Dec 09 2015
    Oil ETFs Dig A Hole But Could Syria Change That? Dec 08 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)